Advertisement
Screener

Personalis, Inc. (PSNL) ROA

Personalis, Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Personalis, Inc. roa for the quarter ending 2026-06-30 was -34.34%, a change of 0.96% year-over-year.
  • Personalis, Inc. roa for the quarter ending 2026-03-31 was -29.36%, a change of 1.39% year-over-year.
  • Personalis, Inc. roa for the quarter ending 2025-12-31 was -24.32%, a change of 5.75% year-over-year.
  • Personalis, Inc. roa for the quarter ending 2025-09-30 was -30.42%, a change of 7.69% year-over-year.
  • Personalis, Inc. roa for fiscal 2025 was -24.32%, a change of 5.75% from fiscal 2024.
  • Personalis, Inc. roa for fiscal 2024 was -30.08%, a change of 18.04% from fiscal 2023.
  • Personalis, Inc. roa for fiscal 2023 was -48.11%, a change of -9.40% from fiscal 2022.
  • Personalis, Inc. roa for fiscal 2022 was -38.71%, a change of -22.26% from fiscal 2021.
Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-34.34%-$107.18M-$31.68M$312.14M
2026-03-31-29.36%-$95.55M-$30.03M$325.4M
2025-12-31-24.32%-$81.27M-$23.81M$334.16M
2025-09-30-30.42%-$73.88M-$21.65M$242.84M
2025-06-30-35.30%-$91.32M-$20.06M$258.68M
2025-03-31-30.76%-$84.07M-$15.75M$273.31M
2024-12-31-30.08%-$81.28M-$16.43M$270.27M
2024-09-30-38.12%-$91.44M-$39.09M$239.89M
2024-06-30-43.91%-$81.45M-$12.80M$185.5M
2024-03-31-47.42%-$92.61M-$12.97M$195.28M
2023-12-31-48.11%-$108.3M-$26.58M$225.1M
2023-09-30-49.76%-$112.78M-$29.10M$226.64M
2023-06-30-44.24%-$110.17M-$23.95M$249.04M
2023-03-31-41.80%-$113.77M-$28.66M$272.18M
2022-12-31-38.71%-$113.32M-$31.07M$292.7M
2022-09-30-32.23%-$102.45M-$26.49M$317.86M
2022-06-30-26.15%-$93.62M-$27.55M$357.98M
2022-03-31-21.29%-$81.03M-$28.21M$380.65M
2021-12-31-16.45%-$65.23M-$20.20M$396.53M
2021-09-30-14.35%-$58.37M-$17.67M$406.69M
2021-06-30-13.11%-$50.24M-$14.95M$383.34M
2021-03-31-11.26%-$44.55M-$12.40M$395.51M
2020-12-31-16.86%-$41.28M-$13.34M$244.84M
2020-09-30-13.90%-$34.58M-$9.54M$248.81M
2020-06-30-21.94%-$31.92M-$9.26M$145.52M
2020-03-31-18.79%-$28.54M-$9.14M$151.88M
2019-12-31-15.95%-$25.08M-$6.64M$157.29M
2019-09-30-13.77%-$21.99M-$6.88M$159.69M
2019-06-30-9.77%-$18.75M-$5.87M$191.85M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-24.32%-$81.27M$334.16M
2024-12-31-30.08%-$81.28M$270.27M
2023-12-31-48.11%-$108.3M$225.1M
2022-12-31-38.71%-$113.32M$292.7M
2021-12-31-16.45%-$65.23M$396.53M
2020-12-31-16.86%-$41.28M$244.84M
2019-12-31-15.95%-$25.08M$157.29M
2018-12-31-47.72%-$19.89M$41.67M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
CareDx, Inc. (CDNA)United States$3.174B13.21
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64